PL442091A1 - Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus - Google Patents

Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Info

Publication number
PL442091A1
PL442091A1 PL442091A PL44209122A PL442091A1 PL 442091 A1 PL442091 A1 PL 442091A1 PL 442091 A PL442091 A PL 442091A PL 44209122 A PL44209122 A PL 44209122A PL 442091 A1 PL442091 A1 PL 442091A1
Authority
PL
Poland
Prior art keywords
uberis
agalactiae
aureus
coli
diagnostic composition
Prior art date
Application number
PL442091A
Other languages
English (en)
Other versions
PL246485B1 (pl
Inventor
Anna DOBRUT
Dagmara Wójcik-Grzybek
Monika BRZYCHCZY-WŁOCH
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL442091A priority Critical patent/PL246485B1/pl
Priority to EP23461639.9A priority patent/EP4343328B1/en
Publication of PL442091A1 publication Critical patent/PL442091A1/pl
Publication of PL246485B1 publication Critical patent/PL246485B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

W zgłoszeniu ujawniono sposób i kompozycję diagnostyczną do wykrywania mastitis wywoływanego przez E. coli, S. uberis, S. agalactiae lub S. aureus, posiadające co najmniej 80% czułość i specyficzność oraz nadające się do łatwego i szybkiego wykonywania testu wykrywającego zapalenie wymion u krów wywoływanego przez wskazane patogeny
PL442091A 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus PL246485B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL442091A PL246485B1 (pl) 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus
EP23461639.9A EP4343328B1 (en) 2022-08-25 2023-08-25 Diagnostic method and composition for the detection of mastitis caused by e. coli, s. uberis, s. agalactiae or s. aureus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL442091A PL246485B1 (pl) 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Publications (2)

Publication Number Publication Date
PL442091A1 true PL442091A1 (pl) 2024-02-26
PL246485B1 PL246485B1 (pl) 2025-02-03

Family

ID=88207674

Family Applications (1)

Application Number Title Priority Date Filing Date
PL442091A PL246485B1 (pl) 2022-08-25 2022-08-25 Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Country Status (2)

Country Link
EP (1) EP4343328B1 (pl)
PL (1) PL246485B1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030073073A1 (en) * 2001-10-11 2003-04-17 Wondu Wolde-Mariam Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
WO2013186885A1 (ja) * 2012-06-13 2013-12-19 旭化成株式会社 乳汁中の特定物質を検出する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948528A2 (en) 1996-11-14 1999-10-13 University of Saskatchewan $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
WO2004018683A1 (en) 2002-08-12 2004-03-04 Akzo Nobel N.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
US20050260695A1 (en) 2003-09-23 2005-11-24 Genprime, Inc. Methods, compositions, devices, and kits for detecting mastitis
US8445215B1 (en) * 2010-07-23 2013-05-21 Nestec S.A. Assays and methods for the detection of Crohn's disease
BR112014003315A2 (pt) 2011-08-15 2017-03-01 Univ Chicago composições e métodos relacionados a anticorpos para a proteína a estafilocócica
WO2019216775A1 (en) 2018-05-10 2019-11-14 Koru Diagnostics Limited Device for detection of antibodies to a pathogen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030073073A1 (en) * 2001-10-11 2003-04-17 Wondu Wolde-Mariam Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
WO2013186885A1 (ja) * 2012-06-13 2013-12-19 旭化成株式会社 乳汁中の特定物質を検出する方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
M.N. ALHUSSIEN, A.K. DANG: "Sci Rep. 2020 Jul 7;10(1):11161", "SENSITIVE AND RAPID LATERAL-FLOW ASSAY FOR EARLY DETECTION OF SUBCLINICAL MAMMARY INFECTION IN DAIRY COWS", *
Y. NAGASAWA ET AL.:: "Front Vet Sci. 2020 Jan 22; 6: 504", "RAPID STAPHYLOCOCCUS AUREUS DETECTION FROM CLINICAL MASTITIS MILK BY COLLOIDAL GOLD NANOPARTICLE-BASED IMMUNOCHROMATOGRAPHIC STRIPS" *

Also Published As

Publication number Publication date
EP4343328A2 (en) 2024-03-27
PL246485B1 (pl) 2025-02-03
EP4343328B1 (en) 2026-03-11
EP4343328A3 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
BR102021005055A2 (pt) detecção de anticorpos para sarsr-cov
Cortimiglia et al. Prevalence of Staphylococcus aureus and methicillin-resistant S. aureus in bulk tank milk from dairy goat farms in Northern Italy
Mir et al. Subclinical mastitis in machine milked dairy farms in Punjab: prevalence, distribution of bacteria and current antibiogram
Berthelot et al. Physiological and pathological thresholds of somatic cell counts in ewe milk
Liu et al. Phylogenetic group, virulence factors and antimicrobial resistance of Escherichia coli associated with bovine mastitis
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
Liu et al. Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients
Xu et al. Ocular pathogens and antibiotic resistance in microbial keratitis over three years in Harbin, Northeast China
MX2023013412A (es) Métodos y composiciones para monitorear el tratamiento de mieloma múltiple recidivante y/o refractario.
CO2024011148A2 (es) Combinaciones fungicidas y métodos para controlar hongos fitopatógenos
PL442091A1 (pl) Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus
Locatelli et al. Effect on quarter milk somatic cell count and antimicrobial susceptibility of Staphylococcus rostri causing intramammary infection in dairy water buffaloes
BR112023024477A2 (pt) Método para determinação de atividade cardíaca ou respiratória de um indivíduo e sistema associado
Paul et al. Bovine mastitis, an economically important bacterial infection of udder in cattle: A review
Karabasanavar et al. Field level interventions on subclinical mastitis and detection of Staphylococcus in crossbred dairy cows
Sundareshan et al. A comparative evaluation of four detection tests and the isolation of coagulase-negative staphylococci from subclinical mastitis cases in south Indian cattle
Haghkhah et al. Evaluation of milk haptoglobin and amyloid A in high producing dairy cattle with clinical and subclinical mastitis in Shiraz
Raheel et al. Phenotypic and genotypic characterization of Streptococci associated with clinical bovine mastitis
Mongkolrattanothai et al. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates
Sana et al. IN VITRO COMPARISON OF DISK DIFFUSION METHOD AND AGAR DILUTION METHOD FOR SENSITIVITY OF POLYMYXIN B AGAINST MULTI DRUG RESISTANT ACINETOBACTER BAUMANNII.
Juozaitienë et al. Association of milk flow curve and prevalence of mastitis pathogens in dairy cows
EP4169939A4 (en) ANTIBODIES, USE THEREOF, PHARMACEUTICAL COMPOSITION WITH METHOD FOR DIAGNOSING FUNGAL INFECTIONS, KIT FOR DIAGNOSING FUNGAL INFECTIONS AND METHOD FOR TREATING FUNGAL INFECTIONS
El-Kady et al. The multi-drug resistance CFR gene: An evolving mechanism for linezolid resistance in Staphylococcus aureus
EP4303322A4 (en) PRIMER-PROBE COMPOSITION, KIT AND DETECTION METHODS
UA160293U (uk) Спосіб визначення впливу сангвірітрину на фактори патогенності метицилін-резистентного staphylococcus aureus